RCN3028

· Yung Shin Pharm. Ind. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RCN3028, covering 2022-02-14 to 2022-02-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women [Phase 2]